Pharmaceuticals & BiotechVepdegestrant's 5-Month PFS Anchors Cross-Border Oncology Deals as 2026 PDUFA Cluster Reshapes Global Drug ValuationsSalvado•May 17, 2026
biotechnologyLeonaBio Risks $140M Market Cap on Single Breast Cancer Trial After Neurodegenerative PivotViaNews Editorial Team•Feb 22, 2026
